Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05679349 · ClinicalTrials.gov registry record · NA
Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
A NA study of Lung Carcinoma and Tobacco-Related Carcinoma, sponsored by Ronald Myers.
- Recruiting
- Registry status
- NA
- Development phase
- 822
- Enrollment target
- 1
- Study location
NCT05679349: Recruiting NA study of Lung Carcinoma and Tobacco-Related Carcinoma, sponsored by Ronald Myers.
NCT05679349 is a NA study of Lung Carcinoma and Tobacco-Related Carcinoma that is actively recruiting participants, run by Ronald Myers. The registered enrollment target is 822 participants, below the 5,022-participant average among 38 other Lung Carcinoma trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05679349, a NA study of Lung Carcinoma and Tobacco-Related Carcinoma, is actively recruiting participants, sponsored by Ronald Myers.
- RECRUITING
- Registry status
- NA
- Development phase
- 822 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial tests how well providing education improves screening for lung cancer in patients with a history of smoking. Screenings may help doctors find lung cancer sooner when it may be easier to treat. Education and counseling may be an effective method to help providers and patients learn about lung cancer screening. Providing education and decision counseling to providers and patients may increase lung cancer screening.
Primary Outcome
LCS will be assessed through an endpoint electronic medical records (EMR) search, supplemented with a question on the participant endpoint survey to capture any LCS performed outside the health system and/or not captured in the EMR.
Conditions Studied
Interventions
- OTHER Survey Administration
- OTHER Electronic Health Record Review
- OTHER Educational Activity
Study Locations (1)
Pennsylvania
- Sidney Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 822 participants |
| Start Date | 2024-04-01 |
| Est. Completion | 2027-04-30 |
| Phase | NA |
What NCT05679349 shows while recruiting
NCT05679349 is an interventional study that assigns participants to a tested intervention. The registered 822 participants enrollment target is mid-sized for trials with a published cap, below the 5,022-participant average among 38 other Lung Carcinoma trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Lung Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Survey Administration is the first listed.
NCT05679349 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05679349 about?
NCT05679349 is a clinical study titled "Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking". This clinical trial tests how well providing education improves screening for lung cancer in patients with a history of smoking. Screenings may help doctors find lung cancer sooner when it may be easier to treat. Education and counseling may be an effective method to help providers and patients lear...
What is the current status of trial NCT05679349?
This trial is currently recruiting. It is a NA study. The enrollment target is 822 participants. The study started on 2024-04-01. Estimated completion is 2027-04-30.
What conditions does trial NCT05679349 study?
This clinical trial studies the following conditions: Lung Carcinoma, Tobacco-Related Carcinoma.
What interventions are being tested in trial NCT05679349?
The interventions under investigation include: Survey Administration (OTHER), Electronic Health Record Review (OTHER), Educational Activity (OTHER).
Who is sponsoring clinical trial NCT05679349?
This trial is sponsored by Ronald Myers, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05679349 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05679349's enrollment target sits among peer trials
822 5th of 38 higher than 34 of 38 other Lung Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool
RECRUITING · NA
-
CONNECTing to LungCare
RECRUITING · NA
-
Engagement of Veterans With Lung Cancer
RECRUITING · NA
-
Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study
RECRUITING · NA
-
Novel INPUT Screening Tool to Improve Illness Understanding in Patients With Metastatic or Incurable Lung Cancer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06091254 · 822 participants · Phase 3
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
- NCT07357389 · 822 participants · NA
Virtual Reality for ICU Delirium Prevention
- NCT06944509 · 824 participants · NA
RADIQAL Study (Radiation Dose and Image Quality Trial)
- NCT04028687 · 820 participants
MDR - PMCF Study for Taperloc Complete Stems
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI